Inovio Pharmaceuticals In... (INO)
NASDAQ: INO
· Real-Time Price · USD
1.86
0.24 (14.81%)
At close: Aug 15, 2025, 3:59 PM
1.89
1.61%
After-hours: Aug 15, 2025, 07:53 PM EDT
Inovio Pharmaceuticals Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -111.37B | -87.88B | -87.89B | -87.9B | -121.64M | -124.94M | -135.12M | -164.58M | -168.43M | -241.39M | -279.82M | -332.3M | -354.69M | -328.33M | -303.66M | -221.05M | -141.71M | -188.74M |
Depreciation & Amortization | 743.96M | 3.11M | 3.13M | 2.53M | 2.8M | 3.11M | 3.5M | 4.68M | 5.01M | 5.27M | 5.5M | 6.39M | 5.89M | 5.31M | 4.73M | 4.38M | 4.37M | 4.21M |
Stock-Based Compensation | 6.11B | 5.28B | 5.28B | 5.28B | 8.38M | 9.79M | 11.07M | 12.08M | 13.24M | 18.65M | 22.56M | 24.76M | 27.14M | 24.45M | 26.34M | 24.69M | 23.23M | 21.24M |
Other Working Capital | -545.61M | -545.41M | -542.45M | -546.58M | -4.59M | -5.5M | 27.56M | 43.35M | 36.94M | 17.64M | -9.07M | -19.02M | -12.49M | 7.06M | -2.37M | -2.24M | -2.18M | -2.21M |
Other Non-Cash Items | 56.79B | 55.66B | 82.51B | 82.51B | 6.7M | 7.11M | 5.38M | 3.51M | -3.23M | 1.47M | 11.69M | 14.75M | 12.63M | 8.37M | 858.64K | 1.52M | 1.55M | 4.11M |
Deferred Income Tax | n/a | n/a | n/a | -32.05K | -32.05K | 1.06M | 1.06M | 5.12M | 5.12M | 4.03M | 4.03M | 2.64M | 4.31M | 3.73M | 5.67M | -1.75M | -59.96M | 34.99M |
Change in Working Capital | -8.36M | -6.59M | -2.66M | -4.04M | -8.57M | -12.59M | -10.26M | 4.76M | -24.48M | 20.97M | 19.83M | 66M | 107.93M | 61.75M | 50.35M | -36.83M | -84.19M | -81.2M |
Operating Cash Flow | -47.73B | -26.95B | -104.08M | -110.69M | -112.36M | -116.46M | -124.37M | -134.43M | -172.78M | -191M | -216.22M | -217.77M | -196.79M | -224.72M | -215.71M | -229.03M | -256.7M | -205.39M |
Capital Expenditures | 487.83K | 35.58K | n/a | 320.9K | -166.93K | 261.4K | n/a | -486.01K | -572.84K | -1.27M | 1.03M | 552.3K | 470.51K | 979.82K | -1.23M | -1.55M | -1.76M | -1.59M |
Cash Acquisitions | 59.32K | 59.32K | 59.32K | n/a | n/a | -53.93M | -47.86M | -45.86M | -90.5M | -26.99M | -35.06M | 1,435.8B | 1,435.8B | 1,435.8B | 1,435.8B | -1.19M | -1.19M | -1.19M |
Purchase of Investments | -59.05B | -54.13B | -54.14B | -54.17B | -126.09M | -132.79M | -203.48M | -219.23M | -215.89M | -229.24M | -248.53M | -244.04M | -180.47M | -173.27M | -348.95M | -311.55M | -325.38M | -374.93M |
Sales Maturities Of Investments | 136.26B | 125.32B | 125.37B | 125.38B | 196.23M | 246.44M | 284.93M | 335.06M | 381.86M | 331.69M | 361.08M | 296.58M | 244.5M | 297.39M | 174.84M | 141.93M | 99M | 58.47M |
Other Investing Acitivies | -71.92B | -71.18B | -71.12B | -71.12B | -172.63K | 53.76M | 73.05M | 71.23M | 115.87M | 52.35M | 31.06M | -1,435.8B | -1,435.8B | -1,435.7B | -1,435.7B | 103.68M | 87.67M | 34.39M |
Investing Cash Flow | 5.28B | 6.94M | 104.07M | 89.37M | 69.8M | 113.74M | 87.36M | 121.41M | 171.46M | 107.25M | 109.59M | 49.09M | 60.49M | 121.1M | -175.34M | -172.57M | -189.41M | -282.1M |
Debt Repayment | 16.41M | 16.41M | n/a | -16.41M | -16.41M | -16.41M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 171.62K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | -424.7K | -424.7K | -424.7K | -424.7K | n/a | n/a | n/a | -80.38K | -80.38K | -80.38K | -80.38K | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -35.21M | 15.54M | 15.44M | 15.79M | 15.79M | -216.19K | -466.65K | -466.65K | -411.39K | -596.79K | -1.11M | -856.07K | -1.34M | 2.32M | 2.06M | 4.21M | 2.7M | 3.89M |
Financial Cash Flow | -3.94M | 63.87M | 51.48M | 24.17M | 24.21M | -5.94M | 5M | 9.82M | 12.94M | 52.99M | 81.84M | 122.77M | 118.52M | 79.02M | 211.5M | 290.84M | 289.59M | 412.67M |
Net Cash Flow | -41.43B | -25.85B | 51.5M | 2.88M | -18.32M | -8.64M | -32.02M | -3.18M | 11.61M | -30.77M | -24.81M | -45.95M | -17.82M | -108.26M | -263.22M | -194.39M | -240.14M | -74.81M |
Free Cash Flow | -132.06B | -111.28B | -84.43B | -84.44B | -120.25M | -123.93M | -132.1M | -142.65M | -173.36M | -192.26M | -215.18M | -217.21M | -196.32M | -223.74M | -216.94M | -230.58M | -258.46M | -206.98M |